Target intelligence / Profile preview

Helicobacter pylori surface structures

Molecular classification
Bacterial surface protein, Adhesin, Lipopolysaccharide, Antigen
01

Overview

Helicobacter pylori surface structures encompass a diverse array of molecular components located on the outer membrane and surface of the bacterium, including adhesins, flagella, lipopolysaccharides (LPS), and outer membrane proteins (OMPs). These structures are critical for the pathogen's ability to survive the acidic environment of the stomach, colonize the gastric mucosa, and evade the host immune system. For instance, adhesins like BabA and SabA mediate binding to host glycoconjugates, while flagella provide the motility necessary to penetrate the mucus layer. These surface components are primary targets for the host's immune response and are being extensively studied as candidates for vaccine development. Pharmacologically, bismuth-based compounds are known to interact with these surface structures, leading to bacterial cell wall degradation and inhibition of enzyme activities. Additionally, novel therapeutic strategies aim to use anti-adhesive molecules to prevent bacterial attachment, thereby facilitating clearance and reducing the risk of chronic infection and associated diseases such as peptic ulcers and gastric adenocarcinoma.

Other names
Helicobacter pylori surface antigensH. pylori outer membrane componentsH. pylori cell surfaceH. pylori surface proteins
02

Mechanism of action

Inhibition of bacterial adhesion to gastric mucosa, disruption of bacterial cell wall and membrane integrity, neutralization of surface-associated enzymes, and induction of protective immune responses through antigenic recognition.

03

Biological functions

AdhesionColonizationMotilityImmune evasionPathogenesis
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric cancerMALT lymphoma
05

Safety considerations

Antibiotic resistance developmentDisruption of the gastric and intestinal microbiomePotential for molecular mimicry leading to autoimmune responses (e.g., anti-Lewis antigen antibodies)
06

Interacting drugs

Bismuth subsalicylate

4 more in the full profile.

07

Biomarkers

Helicobacter pylori stool antigenUrea breath test (detects surface-associated urease activity)Anti-H. pylori IgG antibodiesAnti-H. pylori IgA antibodies

Beyond the preview

Go deeper on Helicobacter pylori surface structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori surface structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call